Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-06

Clinical Trial Update: Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing disturbance of plasma cytokine parameters in clozapine-resistant, treatment-refractory schizophrenia and their associa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED